2325 logo

Yunkang Group Limited Stock Price

SEHK:2325 Community·HK$521.0m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

2325 Share Price Performance

HK$0
-4.70 (-100.00%)
HK$0
-4.70 (-100.00%)
Price HK$0

2325 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Moderate risk and good value.

5 Risks
1 Reward

Yunkang Group Limited Key Details

CN¥645.2m

Revenue

CN¥455.9m

Cost of Revenue

CN¥189.2m

Gross Profit

CN¥910.1m

Other Expenses

-CN¥720.9m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
-1.23
29.33%
-111.74%
91.0%
View Full Analysis

About 2325

Founded
2008
Employees
1146
CEO
Yong Zhang
WebsiteView website
www.yunkanghealth.com

Yunkang Group Limited operates as a medical operation service provider in the People's Republic of China. The company offers diagnostic testing services for medical institution alliances, including setting up or upgrading diagnostic centers, the establishment of standard operating procedures for diagnostic testing, diagnostic consultation and staff training, procurement of equipment, smart internet of things, and logistics assistance. It also provides diagnostic outsourcing services comprising pathology tests; infectious disease diagnostic tests; and genetic reproduction and screening tests. In addition, the company offers routine diagnostic tests for chronic kidney, blood, autoimmune, endocrine metabolism, and other diseases. Further, it provides diagnostic testing services for financial institutions and insurance companies, including personalized diagnostic testing, medical report consultation, and hospital referral services; information technology, medical logistics, and reagent and medical equipment procurement; healthcare technology development; and project investment services. The company provides its services through independent clinical laboratories and on-site diagnostic centers. Yunkang Group Limited was founded in 2008 and is headquartered in Guangzhou, the People's Republic of China.

Recent 2325 News & Updates

Recent updates

No updates